Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-16

Clinical Trial Update: Safety and Efficacy Study of Triamcinolone Acetonide DuraPeel to Treat Hand Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of Triamcinolone Acetonide DuraPeel for hand dermatitis has completed, evaluating safety and efficacy in treating the conditio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triamcinolone Acetonide DuraPeel (Triamcinolone acetonide)

Snippet

Sponsor: ZARS Pharma Inc. | Conditions: Hand Dermatoses | Phase 2 | Status: COMPLETED